“…The primary indication for LT was reported in 180 of the 328 patients, with 95 patients having biliary atresia and 34 having a metabolic disease (unable to distinguish between cirrhotic and noncirrhotic metabolic disease). [8,15,17,19,20,22,23,26,29,31] Donor type was reported in 216 of the 328 patients, with 39.4% (85 of 216) of patients having undergone living donor LT. [5,8,16,17,19,20,22,23,[25][26][27][28]30] Missing data prevented us from analyzing the impact of primary indication, donor type, and the other potential risk factors for each treatment.…”